Doxycycline

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Doxycycline hyclate)
Jump to: navigation, search
206px }}
Doxycycline
Systematic (IUPAC) name
(2-(amino-hydroxy-methylidene)-4-dimethylamino

-5,10,11,12a-tetrahydroxy-6-methyl- 4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione

Identifiers
CAS number 564-25-0
ATC code J01AA02 A01AB22
PubChem 11256
DrugBank APRD00597
Chemical data
Formula C22H24N2O8 
Mol. mass 444.435 g/mol
Pharmacokinetic data
Bioavailability 100%
Metabolism hepatic
Half life 18-22 hours
Excretion urine, feces
Therapeutic considerations
Pregnancy cat.

D(US)

Legal status

POM(UK) -only(US)

Routes oral, periodontal, iv, im

WikiDoc Resources for

Doxycycline

Articles

Most recent articles on Doxycycline

Most cited articles on Doxycycline

Review articles on Doxycycline

Articles on Doxycycline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Doxycycline

Images of Doxycycline

Photos of Doxycycline

Podcasts & MP3s on Doxycycline

Videos on Doxycycline

Evidence Based Medicine

Cochrane Collaboration on Doxycycline

Bandolier on Doxycycline

TRIP on Doxycycline

Clinical Trials

Ongoing Trials on Doxycycline at Clinical Trials.gov

Trial results on Doxycycline

Clinical Trials on Doxycycline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Doxycycline

NICE Guidance on Doxycycline

NHS PRODIGY Guidance

FDA on Doxycycline

CDC on Doxycycline

Books

Books on Doxycycline

News

Doxycycline in the news

Be alerted to news on Doxycycline

News trends on Doxycycline

Commentary

Blogs on Doxycycline

Definitions

Definitions of Doxycycline

Patient Resources / Community

Patient resources on Doxycycline

Discussion groups on Doxycycline

Patient Handouts on Doxycycline

Directions to Hospitals Treating Doxycycline

Risk calculators and risk factors for Doxycycline

Healthcare Provider Resources

Symptoms of Doxycycline

Causes & Risk Factors for Doxycycline

Diagnostic studies for Doxycycline

Treatment of Doxycycline

Continuing Medical Education (CME)

CME Programs on Doxycycline

International

Doxycycline en Espanol

Doxycycline en Francais

Businness

Doxycycline in the Marketplace

Patents on Doxycycline

Experimental / Informatics

List of terms related to Doxycycline

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Doxycycline (INN) (IPA: [ ˌdɒksɪˈsaɪklin ]) is a member of the tetracycline antibiotics group and is commonly used to treat a variety of infections. Doxycycline is a semi-synthetic tetracycline invented and clinically developed in the early 1960s by Pfizer Inc. and marketed under the brand name Vibramycin. Vibramycin received FDA approval in 1967, becoming Pfizer's first once-a-day broad-spectrum antibiotic. Other brand names include Monodox, Periostat, Vibra-Tabs, Doryx, Vibrox, Adoxa®, Doxyhexal and Atridox (topical doxycycline hyclate for Periodontitis).

Indicated uses

Further information: oxytetracycline

As well as the general indications for all members of the tetracycline antibiotics group, Doxycycline is frequently used to treat chronic prostatitis, sinusitis, syphilis, chlamydia, pelvic inflammatory disease[1][1], acne and rosacea[1][1]. In addition it is used in the treatment and prophylaxis of Bacillus anthracis (anthrax) and in prophylaxis against malaria. It should not be used alone for initial treatment of malaria, even when the parasite is doxycyline-sensitive, because the antimalarial effect of doxycyline is delayed. This delay is related to its mechanism of action. Its mechanism of action against malaria is to specifically impair in the progeny the apicoplast genes resulting in their abnormal cell division.[1]

It is also effective against Yersinia pestis (the infectious agent of bubonic plague) and is prescribed for the treatment of Lyme disease[1][1][1], ehrlichiosis[1][1] and Rocky Mountain spotted fever. Doxycycline, like other antibiotics, will not work for colds, flu, or other viral infections.

Elephantiasis is a disease caused by a nematode (worm) Wuchereria bancrofti. It causes swollen limbs and genitals (Filariasis) and affects over 120 million people in the world. Previous anti-nematode treatments have been limited by poor levels of effectiveness, drug side effects and high costs. Doxycycline was shown in 2003 to kill the symbiotic Wolbachia bacteria upon which the nematodes are dependent.[1] Field trials in 2005 showed that Doxycycline almost completely eliminates blood-borne filaria when given for an 8 week course.[1][1]

When bacteriologic testing indicates appropriate susceptibility to the drug, doxycycline may be used to treat:

Generic 100 mg doxycycline capsules
Generic 100 mg doxycycline capsules

Cautions and side effects

Cautions and side effects are similar to other members of the tetracycline antibiotic group. However the 10% risk of photosensitivity skin reactions is of particular importance for those intending long-term use for malaria prophylaxis. Reports of GERD have been cited with the use of Doxycycline.

Unlike some other members of the tetracycline group, it may be used in those with renal impairment.

Doxycycline impairs the effectiveness of many types of hormonal contraception due to CYP450 induction, and physicians recommend the use of barrier contraception for people taking the drug to prevent unwanted pregnancy. It may also reduce the effectiveness of oral contraceptives by decreasing the normal flora in the intestines. Normally, estrogens inside oral contraceptives are glucuronidated in the liver and re-circulated to the gut. Flora presence in the gut help to remove glucuronide groups off of estrogen as it re-enters the GI tract via enterohepatic circulation and thus the estrogen takes effect. However, the decrease of number of flora inside the gut reduce the flora's glucuronide groups removal ability. Therefore, Doxycycline's decrease the efficacy of oral contraceptives up to two-fold.

It should be taken with a full glass of water to prevent irritation of the esophagus and stomach. Also, there is a slim risk of liver damage during prolonged use of the drug.[1]

Experimental applications

At subantimicrobial doses, doxycycline is an inhibitor of matrix metalloproteinases, and has been used in various experimental systems for this purpose. Doxycycline has been used successfully in the treatment of one patient with lymphangioleiomyomatosis, an otherwise progressive and fatal disease.[1]

Doxycycline is also used in "Tet-on" and "Tet-off" tetracycline controlled transcriptional activation to regulate transgene expression in organisms and cell cultures.

Other experimental applications include:

References

External links

zh-min-nan:Doxycycline de:Doxycyclinfr:Doxycycline nl:Doxycycline ja:ドキシサイクリンth:ด็อกซีซัยคลิน


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools